Search Results

18 articles with title/keywords/abstract containing Deal-licensing

Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
modify search
Display per page 

Sublingual fentanyl tablet approved in the UK.

Source: Inpharma, Volume 1, Number 1658, 2008-10-04 , pp. 18-18(1)

Publisher: Adis International

Biopten [sapropterin] approved in Japan for phenylketonuria.

Source: Inpharma, Volume 1, Number 1648, 2008-07-26 , pp. 22-22(1)

Publisher: Adis International

A novel anti-sense drug, ATL 1102, has shown promise for the treatment of patients with relapsing-remitting multiple sclerosis

Source: Inpharma, Volume 1, Number 1646, 2008-07-12 , pp. 12-12(1)

Publisher: Adis International

Lubiprostone approved for IBS with constipation in US women.

Source: Inpharma, Volume 1, Number 1637, 2008-05-10 , pp. 22-22(1)

Publisher: Adis International

First peripheral drug-eluting stent launched in NZ.

Source: Inpharma, Volume 1, Number 1633, 2008-04-12 , pp. 22-22(1)

Publisher: Adis International

Fifth dose of DTP vaccine approved in US.

Source: Inpharma, Volume 1, Numbers 1630-1631, 2008-03-22 , pp. 18-18(1)

Publisher: Adis International

Once-daily tramadol approved in two new markets.

Source: Inpharma, Volume 1, Number 1626, 2008-02-23 , pp. 22-22(1)

Publisher: Adis International

The US FDA has approved ZymoGenetics' topical recombinant thrombin [Recothrom] as an aid to haemostasis.

Source: Inpharma, Volume 1, Number 1622, 2008-01-26 , pp. 22-22(1)

Publisher: Adis International

An oral insulin spray [Generex Oral-lyn; Generex Biotechnology] has been approved in India for the treatment of diabetes mellitus.

Source: Inpharma, Volume 1, Number 1613, 2007-11-10 , pp. 23-23(1)

Publisher: Adis International

Transdermal ketoprofen keeps knee OA pain in control

Source: Inpharma, Volume 1, Number 1550, 2006-08-12 , pp. 9-9(1)

Publisher: Adis International

GSK provides further aid in the fight against HIV/AIDS

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 505, 2006-06-17 , pp. 10-10(1)

Publisher: Adis International

Chiesi Farmaceutici and Laboratorios SALVAT have signed a worldwide development and licensing agreement for new muscarinic M3 receptor antagonists.

Source: Inpharma, Volume 1, Number 1522, 2006-01-28 , pp. 8-8(1)

Publisher: Adis International

Oseltamivir sub-license granted in India

Source: PharmacoEconomics and Outcomes News, Volume 1, Number 494, 2006-01-14 , pp. 15-15(1)

Publisher: Adis International

A genetic test (UGT1A1) to determine patients likely to have serious adverse effects to Camptosar [irinotecan] has been licensed

Source: Reactions, Volume 1, Number 1084, 2006-01-14 , pp. 2-2(1)

Publisher: Adis International

Abarelix 100mg powder for injectable suspension [Plenaxis; Praecis Pharmaceuticals] has received approval in Germany

Source: Inpharma, Volume 1, Number 1508, 2005-10-08 , pp. 22-22(1)

Publisher: Adis International

Monovalent Oral Polio Vaccine 1 [MOPV-1; sanofi pasteur] has been licensed for use

Source: Inpharma, Volume 1, Number 1482, 2005-04-09 , pp. 26-26(1)

Publisher: Adis International

XR 311 [TransMID; Xenova Group] has been granted orphan drug status by the Ministry of Health, Labour and Welfare in Japan.

Source: Inpharma, Volume 1, Number 1475, 2005-02-19 , pp. 22-22(1)

Publisher: Adis International

Chiron Corporation has announced the approval of its new meningococcal group B vaccine for New Zealand [MeNZB].

Source: Inpharma, Volume 1, Number 1446, 2004-07-17 , pp. 18-18(1)

Publisher: Adis International

modify search
Key:
Free Content - Free Content
New Content - New Content
Subscribed Content - Subscribed Content
Free Trial Content - Free Trial Content
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages.
Page Help Click here for Page Help
Shopping cart
Tools
Sign in






Need to register?
Sign up here
Text size: A | A | A | A